{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:31Z","timestamp":1786120231387,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/rlu.0b013e318219ae29","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T19:11:28Z","timestamp":1317755488000},"page":"872-878","source":"Crossref","is-referenced-by-count":21,"title":["Diagnostic Performance of In-111 Capromab Pendetide SPECT\/CT in Localized and Metastatic Prostate Cancer"],"prefix":"10.1097","volume":"36","author":[{"given":"William J.","family":"Rieter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Ahlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton T.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie L.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210204","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1148\/radiol.2431030580","article-title":"Imaging prostate cancer: a multidisciplinary perspective.","volume":"243","author":"Hricak","year":"2007","journal-title":"Radiology"},{"key":"R2-6-20210204","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.rcl.2006.10.008","article-title":"Imaging of prostate cancer.","volume":"45","author":"Akin","year":"2007","journal-title":"Radiol Clin North Am"},{"key":"R3-6-20210204","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/01.mou.0000165549.94663.2d","article-title":"Update on magnetic resonance imaging, ProstaScint, and novel imaging in prostate cancer.","volume":"15","author":"Brassell","year":"2005","journal-title":"Curr Opin Urol"},{"key":"R4-6-20210204","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ncpuro0452","article-title":"Technology insight: monoclonal antibody imaging of prostate cancer.","volume":"3","author":"Bander","year":"2006","journal-title":"Nat Clin Pract Urol"},{"key":"R5-6-20210204","first-page":"927","article-title":"Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.","volume":"7","author":"Horoszewicz","year":"1987","journal-title":"Anticancer Res"},{"key":"R6-6-20210204","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/(SICI)1097-0045(19970301)30:4<232::AID-PROS2>3.0.CO;2-N","article-title":"Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line.","volume":"30","author":"Troyer","year":"1997","journal-title":"Prostate"},{"key":"R7-6-20210204","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues.","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res"},{"key":"R8-6-20210204","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0090-4295(96)00184-7","article-title":"Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy.","volume":"48","author":"Wright","year":"1996","journal-title":"Urology"},{"key":"R9-6-20210204","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0090-4295(98)00278-7","article-title":"Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases.","volume":"52","author":"Sweat","year":"1998","journal-title":"Urology"},{"key":"R10-6-20210204","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/pros.2990180305","article-title":"Immunoscintigraphy of prostatic cancer: preliminary results with 111In-labeled monoclonal antibody 7E11-C5.3 (CYT-356).","volume":"18","author":"Wynant","year":"1991","journal-title":"Prostate"},{"key":"R11-6-20210204","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0090-4295(99)00314-3","article-title":"Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.","volume":"54","author":"Manyak","year":"1999","journal-title":"Urology"},{"key":"R12-6-20210204","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2214\/ajr.183.2.1830519","article-title":"Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer.","volume":"183","author":"Schettino","year":"2004","journal-title":"Am J Roentgenol"},{"key":"R14-6-20210204","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/MOU.0b013e3282f13ac3","article-title":"The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery.","volume":"18","author":"Pucar","year":"2008","journal-title":"Curr Opin Urol"},{"key":"R15-6-20210204","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijrobp.2007.10.020","article-title":"Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer.","volume":"71","author":"Koontz","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R16-6-20210204","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ijrobp.2007.11.053","article-title":"Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?","volume":"71","author":"Liauw","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-6-20210204","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1200\/JCO.1998.16.1.284","article-title":"Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy.","volume":"16","author":"Kahn","year":"1998","journal-title":"J Clin Oncol"},{"key":"R18-6-20210204","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2003.05.138","article-title":"Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy.","volume":"21","author":"Thomas","year":"2003","journal-title":"J Clin Oncol"},{"key":"R19-6-20210204","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0022-5347(05)00982-1","article-title":"The impact of a negative (111)indium-capromab pendetide scan before salvage radiotherapy.","volume":"175","author":"Proano","year":"2006","journal-title":"J Urol"},{"key":"R20-6-20210204","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2006.09.026","article-title":"Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer.","volume":"67","author":"Nagda","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-6-20210204","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.urology.2010.01.082","article-title":"Capromab pendetide scanning has a potential role in optimizing patient selection for salvage cryosurgical ablation of the prostate.","volume":"76","author":"El-Zawahry","year":"2010","journal-title":"Urology"},{"key":"R23-6-20210204","first-page":"24","article-title":"Salvage cryosurgical ablation of the prostate for local recurrence after radiation therapy: improved outcomes utilizing a capromab pendetide scan and biopsy algorithm.","volume":"14","author":"Clarke","year":"2007","journal-title":"Can J Urol"},{"key":"R24-6-20210204","first-page":"146","article-title":"Use of radioimmunoscintigraphy with indium-111-labeled CYT-356 (ProstaScint) scan for evaluation of patients for salvage brachytherapy.","volume":"6","author":"Fang","year":"2000","journal-title":"Tech Urol"},{"key":"R25-6-20210204","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brachy.2006.11.002","article-title":"Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT\/CT capromab pendetide.","volume":"6","author":"Ellis","year":"2007","journal-title":"Brachytherapy"},{"key":"R26-6-20210204","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.urology.2007.03.069","article-title":"Central abdominal uptake of indium-111 capromab pendetide (ProstaScint) predicts for poor prognosis in patients with prostate cancer.","volume":"70","author":"Haseman","year":"2007","journal-title":"Urology"},{"key":"R27-6-20210204","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.juro.2009.05.047","article-title":"Use of In-111 capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland.","volume":"182","author":"Mouraviev","year":"2009","journal-title":"J Urol"},{"key":"R29-6-20210204","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1442-2042.2009.02413.x","article-title":"Utilization of (111)In-capromab pendetide SPECT-CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy.","volume":"16","author":"Kimura","year":"2009","journal-title":"Int J Urol"},{"key":"R30-6-20210204","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.juro.2009.05.131","article-title":"Editorial comment.","volume":"182","author":"Bander","year":"2009","journal-title":"J Urol"},{"key":"R31-6-20210204","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.juro.2009.05.132","article-title":"Editorial comment.","volume":"182","author":"Ellis","year":"2009","journal-title":"J Urol"},{"key":"R32-6-20210204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.semnuclmed.2006.07.002","article-title":"Synergistic value of single-photon emission computed tomography\/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.","volume":"37","author":"Sodee","year":"2007","journal-title":"Semin Nucl Med"},{"key":"R33-6-20210204","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"key":"R34-6-20210204","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1001\/jama.2009.674","article-title":"A 64-year-old man with low-risk prostate cancer: review of prostate cancer treatment.","volume":"301","author":"Sanda","year":"2009","journal-title":"JAMA"},{"key":"R35-6-20210204","first-page":"610","article-title":"Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.","volume":"44","author":"Smith-Jones","year":"2003","journal-title":"J Nucl Med"},{"key":"R36-6-20210204","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2967\/jnumed.109.067108","article-title":"In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT\/CT.","volume":"51","author":"Seo","year":"2010","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003072-201110000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:19:37Z","timestamp":1786047577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003072-201110000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e318219ae29","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}